Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1973 1
1981 2
1982 1
1983 1
1985 1
1986 5
1987 3
1988 4
1989 1
1990 1
1991 3
1992 1
1993 2
1994 2
1995 2
1996 2
1997 4
1998 3
1999 2
2000 1
2001 1
2002 4
2003 3
2004 3
2005 2
2006 3
2007 4
2008 7
2009 8
2010 11
2011 3
2012 8
2013 9
2014 12
2015 7
2016 11
2017 11
2018 10
2019 14
2020 16
2021 14
2022 8
2023 14
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

211 results

Results by year

Filters applied: . Clear all
Page 1
Use of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes and Cardiovascular Disease: A Review.
Honigberg MC, Chang LS, McGuire DK, Plutzky J, Aroda VR, Vaduganathan M. Honigberg MC, et al. JAMA Cardiol. 2020 Oct 1;5(10):1182-1190. doi: 10.1001/jamacardio.2020.1966. JAMA Cardiol. 2020. PMID: 32584928 Free PMC article. Review.
Out-of-pocket costs and secondary advantages (eg, weight loss) may inform shared decision-making discussions regarding potential therapies. GLP-1RA therapy has a favorable safety profile. Its most common adverse effect is gastrointestinal upset, which typically wane …
Out-of-pocket costs and secondary advantages (eg, weight loss) may inform shared decision-making discussions regarding potential ther …
"Hear me!".
Chiakpo E. Chiakpo E. J Patient Exp. 2021 Feb 4;8:2374373521989248. doi: 10.1177/2374373521989248. eCollection 2021. J Patient Exp. 2021. PMID: 34179363 Free PMC article.
This patient was very succinct with her demands and understandably upset with our blatant conjectures with our daily mundane clinical rounds and consults. ...
This patient was very succinct with her demands and understandably upset with our blatant conjectures with our daily mundane clinical …
Return-To-Play Decision Making in Team Sports Athletes. A Quasi-Naturalistic Scenario Study.
Mayer J, Burgess S, Thiel A. Mayer J, et al. Front Psychol. 2020 Jun 3;11:1020. doi: 10.3389/fpsyg.2020.01020. eCollection 2020. Front Psychol. 2020. PMID: 32581922 Free PMC article.
Competitive athletes act within cultures of risk in sports and often decide to return to sport despite having acute health problems. The outcomes of such risky return-to-play decisions can not only negatively affect their future health, but may also limit their sports perf …
Competitive athletes act within cultures of risk in sports and often decide to return to sport despite having acute health problems. The out …
Promoting shared decision making in advanced cancer: Development and piloting of a patient communication aid.
Henselmans I, Brugel SD, de Haes HCJM, Wolvetang KJA, de Vries LM, Pieterse AH, Baas-Thijssen MCM, de Vos FYF, van Laarhoven HWM, Smets EMA. Henselmans I, et al. Patient Educ Couns. 2019 May;102(5):916-923. doi: 10.1016/j.pec.2018.12.018. Epub 2018 Dec 14. Patient Educ Couns. 2019. PMID: 30591283
OBJECTIVE: To learn how to configure a patient communication aid (PCA) to facilitate shared decision-making (SDM) about treatment for advanced cancer. METHODS: The PCA consists of education about SDM, a question prompt list, and values clarification methods. ...RESULTS: Re …
OBJECTIVE: To learn how to configure a patient communication aid (PCA) to facilitate shared decision-making (SDM) about treatment for …
Enhancing treatment decision-making: pilot study of a treatment decision aid in stage IV non-small cell lung cancer.
Leighl NB, Shepherd FA, Zawisza D, Burkes RL, Feld R, Waldron J, Sun A, Payne D, Bezjak A, Tattersall MH. Leighl NB, et al. Br J Cancer. 2008 Jun 3;98(11):1769-73. doi: 10.1038/sj.bjc.6604395. Epub 2008 May 27. Br J Cancer. 2008. PMID: 18506180 Free PMC article.
We developed a decision aid (DA) for patients with metastatic non-small cell lung cancer (NSCLC), to better inform patients of their prognosis and treatment options, and facilitate involvement in decision-making. ...Patients rated the DA highly with respect to infor …
We developed a decision aid (DA) for patients with metastatic non-small cell lung cancer (NSCLC), to better inform patients of their …
Nrf2 activator PB125® as a carnosic acid-based therapeutic agent against respiratory viral diseases, including COVID-19.
McCord JM, Hybertson BM, Cota-Gomez A, Gao B. McCord JM, et al. Free Radic Biol Med. 2021 Nov 1;175:56-64. doi: 10.1016/j.freeradbiomed.2021.05.033. Epub 2021 May 28. Free Radic Biol Med. 2021. PMID: 34058321 Free PMC article. Review.
Nrf2 is a transcription actor that helps maintain metabolic balance by providing redox-sensitive expression of numerous genes controlling normal day-to-day metabolic pathways. When ordinary metabolism is upset by extraordinary events such as injury, pathogenic infection, a …
Nrf2 is a transcription actor that helps maintain metabolic balance by providing redox-sensitive expression of numerous genes controlling no …
Serious Illness Conversations in ESRD.
Mandel EI, Bernacki RE, Block SD. Mandel EI, et al. Clin J Am Soc Nephrol. 2017 May 8;12(5):854-863. doi: 10.2215/CJN.05760516. Epub 2016 Dec 28. Clin J Am Soc Nephrol. 2017. PMID: 28031417 Free PMC article. Review.
Many nephrologists shy away from these conversations, because they do not wish to upset their patients, feel that there is too much uncertainty in their ability to predict prognosis, are insecure in their skills at broaching the topic, or have difficulty incorporating the …
Many nephrologists shy away from these conversations, because they do not wish to upset their patients, feel that there is too much u …
Non-CGRP Antagonist/Non-Triptan Options for Migraine Disease Treatment: Clinical Considerations.
Ingram EE, Bocklud BE, Corley SC, Granier MA, Neuchat EE, Ahmadzadeh S, Shekoohi S, Kaye AD. Ingram EE, et al. Curr Pain Headache Rep. 2023 Oct;27(10):497-502. doi: 10.1007/s11916-023-01151-0. Epub 2023 Aug 16. Curr Pain Headache Rep. 2023. PMID: 37584847 Review.
Clinicians have other options for evidence-based treatment of episodic migraine attacks. Treatment decisions should consider contraindications, the effectiveness of alternatives, and potential side effects. ...The anti-epileptic drugs topiramate and divalproex sodium and a …
Clinicians have other options for evidence-based treatment of episodic migraine attacks. Treatment decisions should consider contrain …
Health Impact Assessment of an oil drilling project in California.
McCallum LC, Souweine K, McDaniel M, Koppe B, McFarland C, Butler K, Ollson CA. McCallum LC, et al. Int J Occup Med Environ Health. 2016;29(2):229-53. doi: 10.13075/ijomeh.1896.00551. Int J Occup Med Environ Health. 2016. PMID: 26670354 Free article. Review.
The HIA considered 17 determinants of health that fell under 6 major categories (i.e., air quality, water and soil quality, upset conditions, noise and light emissions, traffic, and community livability). ...This approach and methodology will assist practitioners, stakehol …
The HIA considered 17 determinants of health that fell under 6 major categories (i.e., air quality, water and soil quality, upset con …
A prospective study of primary surrogate decision makers' knowledge of intensive care.
Rodriguez RM, Navarrete E, Schwaber J, McKleroy W, Clouse A, Kerrigan SF, Fortman J. Rodriguez RM, et al. Crit Care Med. 2008 May;36(5):1633-6. doi: 10.1097/CCM.0b013e31816a0784. Crit Care Med. 2008. PMID: 18434916
MEASUREMENTS AND MAIN RESULTS: Of eligible primary surrogate decision makers, 81 were enrolled; 96% had spoken to hospital staff. ...Forty-seven percent of primary surrogate decision makers met the predetermined criteria for good understanding with no significant di …
MEASUREMENTS AND MAIN RESULTS: Of eligible primary surrogate decision makers, 81 were enrolled; 96% had spoken to hospital staff. ... …
211 results